Rabies Treatment: Improving Healthcare Infrastructure, and Emphasis on Prevention of Diseases Has Led to Growth of The Market at a CAGR of 5.20% During Forecasted Period

Pune, India, 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the rabies treatment market.

Market Highlights

Rabies virus is a virus that causes rabies in humans and animals and its transmission can occur through the saliva of animals. Immunization and vaccination are the most important preventive measures for this disease. Treatment by vaccination is the best and most effective method in treating rabies. One of the approved and effective methods against rabies is when inactivated rabies vaccine is combined with rabies immune globulin. Rabies is diagnosed by detecting proteins present on the surface of rabies virus using samples such as, blood samples, saliva samples, and skin samples. Signs and symptoms of rabies include headache, nausea, vomiting, confusion, hyperactivity, difficulty swallowing, agitation, anxiety, hallucinations, insomnia, partial paralysis, hydrophobia (fear of water), and excessive salivation.

The global Rabies Treatment Market is expected to be valued at USD 3141.5 Million by 2030, growing at an 5.20% CAGR during forecast 2022-2030.

Increasing population of stray dogs, and other rabies infected animals, production of contamination-free vaccines using novel culture media, regulatory examinations, and conduction of awareness program by government promotes the growth of rabies treatment market. Various government organizations such as Food and Agriculture Organization (FAO), Global Alliance for Rabies Control (GARC), WHO, and International Organisation for Animal Health (OIE) teamed up together in 2015 to achieve strategic plan of "Zero human Rabies deaths by 2030".

However, high cost of rabies treatment, and poor healthcare expenditure in the developing countries may hamper the growth of the market

Regional Analysis

On regional basis, global rabies treatment market is segmented into America, Europe, Asia Pacific and the Middle East & Africa.

The Americas is the largest market in the world due to major initiatives taken by the government for vaccination against many diseases as well as excellent management of public awareness programs are boosting the growth of the market.

Europe is the second largest market owing to availability of funds for research and development activities and growing emphasis on research and development.

Government is providing tax benefits for people having dogs, cats and other companion animals Governments in the developing countries of Asia Pacific have undertaken various vaccinations programs. India is expected to be an emerging and the fastest growing market. The market shows steady growth in the Middle East & Africa due to the demand for rabies vaccine is less than other regions across the globe.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Rabies Treatment Market Research Report

Segmentation

The rabies treatment market is segmented on the basis of type of rabies, type of treatment, and end users.

On the basis of type of rabies, market is segmented into furious rabies, paralytic rabies and others

On the basis of type of treatment, market is classified into rabies immunoglobin vaccine, bran tissue vaccine, tissue culture and others.

On the basis of end-users, market is segmented into hospitals, clinics, epidemic prevention centres and others.

Key Players

Some of key the players in the rabies treatment market are Sanofi (France), Merck & Co. Inc. , CSC Pharmaceuticals International , Pfizer (U.S.), VBI Vaccines Inc. (U.S.), Taj Pharmaceuticals Limited (India), Bio Med Pvt. Ltd., Bavarian Nordic(U.S.), Solvay(U.S.), Informa plc.(U.S.)  and others.